New reproductive and bodily intervention biotechnologies not only promise to cure or prevent diseases, but are also shaping a new regime of bodily normalization that redefines which lives are desirable, correctable, or eliminable. For several years, countries such as Iceland have stood out for medical procedures that identify the conditions under which a fetus is developing and then ask parents whether they wish to continue or terminate the pregnancy. Between 80–85% of pregnant women in Iceland undergo prenatal screening and, when the result is positive for trisomy 21, termination rates approach 100%. In Denmark the percentage is 98%, in France 77%, and in the United States 67%. Geneticist Kari Stefansson, founder of deCODE Genetics, stated: “My understanding is, basically, that we have almost eradicated Down syndrome from our society; there will hardly ever again be a child with Down syndrome in Iceland” (Quijano, 2017). (read more...)